drugset / Trial / NCT00043914

Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy

NCT00043914

Phase 4 Completed 72 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelTreatment

Summary

This study includes patients 16 years of age or older with a confident diagnosis of epilepsy who are currently treated with an antiepileptic drug (AED) monotherapy but require a change in therapy due to inadequate seizure control and/or unacceptable side effects.

Timeline

Start
2002-01-14
Primary completion
2003-01-29
Completion
2003-01-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 500 mg

Indications